Effect of Chahel tablets in patients having Stress Issues.
- Conditions
- Health Condition 1: F419- Anxiety disorder, unspecified
- Registration Number
- CTRI/2023/10/058410
- Lead Sponsor
- Ambic Ayurved India Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Subject from 18-65 years of age.
2.Subject suffering from one or multiple mental health Issues from- anxiety, insomnia, depression etc;
3.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
4.Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.
1.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids.
2.Subjects that have participated in any other interventional clinical trial in the previous 30 days.
3.Subjects with known sensitivity to any of the constituents of the investigational product.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Stress Issues calculated as SGA <br/ ><br>Change in Cortisol level <br/ ><br>Change in EEG Assessment calculated as alpha, beta and thetaTimepoint: Time frame 0-30 days <br/ ><br>Time frame 0-30 days <br/ ><br>Time frame 0-30 days
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable